International Journal of Clinical Research
International Journal of Clinical Research. 2024; 8: (10) ; 10.12208/j.ijcr.20240408 .
总浏览量: 143
1 内蒙古医科大学蒙医临床医学院 内蒙古呼和浩特
2 内蒙古自治区国际蒙医医院 内蒙古呼和浩特
*通讯作者: 萨仁格日乐,单位: 内蒙古自治区国际蒙医医院 内蒙古呼和浩特;
末梢神经炎作为临床中一种常见且多发的疾病,尤其倾向于在罹患代谢障碍性疾病及接受神经毒性药物治疗的患者中出现。其临床特征显著,主要包括肢体末梢区域的麻木感、疼痛感、肿胀现象、无力现象,乃至严重时可导致肌肉萎缩等症状。在蒙医传统医学理论体系中,珍宝丸作为一种具有代表性的珍贵方剂,被广泛视为治疗神经系统相关疾病的常用药物。本文旨在通过系统回顾与深入分析现有文献资料,系统地整理并归纳蒙药珍宝丸在治疗末梢神经炎领域的基础药理学研究成果与临床实践经验。从而为临床医疗实践提供新颖的治疗思路与坚实的理论支撑。
As a common and frequent clinical disease, peripheral neuritis tends to occur especially in patients with metabolic disorders and neurotoxic drugs. Its clinical features are significant, mainly including numbness, pain, swelling, weakness, and even muscle atrophy in severe cases. In the traditional medical system of Mongolian medicine, Zhenbao Pill, as a representative and precious medicine, is widely regarded as a common medicine for the treatment of neurological diseases. The purpose of this article is to systematically review and analyze the existing literature to systematically sort out and summarize the basic pharmacological research results and clinical practice experience of Mengyao Zhenbao Pill in the field of treatment of peripheral neuritis. In this way, it provides novel treatment ideas and solid theoretical support for clinical medical practice.
[1] 喻珮,刘璐,李志娟,等.针刺治疗多发性末梢神经炎临床研究现状分析[J].中国医药导报,2019,16(28):142-146.
[2] 内蒙古医学院蒙医临床教研组.蒙医内科学[M].呼和浩特:内蒙古人民出版社,1976.286-291.
[3] 伊希巴拉珠尔.甘露四部[M].赤峰:内蒙古科学技术出版社,2015,08:297+548-549.
[4] 巴根那主编.蒙医方剂学[M].内蒙古人民出版社,呼和浩特,2007.4:267-269.
[5] 莲花.额尔敦—乌日勒对MCAO/R损伤大鼠海马及皮质神经营养因子的影响[D].北京中医药大学,2014.
[6] 第司·桑杰嘉措.《兰塔布》[M].赤峰:内蒙古科学技术出版社,2013,11:375-376.
[7] 伟华.基于网络药理学探讨蒙药珍宝丸修复萨病(脑卒中)神经损伤作用机制[D].内蒙古民族大学,2023.
[8] 其布日. 额尔敦-乌日勒的活性成分分析及其对小胶质细胞基因调控作用的研究[D]. 内蒙古大学, 2021.
[9] 翟书鹏,周国平,贾航.周围神经损伤修复术后口服蒙药珍宝丸对功能恢复的作用[J].中国民族医药杂志,2022, 28(03): 30-31+62.
[10] 赵光辉.蒙药珍宝丸治疗糖尿病周围神经病变痰瘀互阻证的临床效果[J].中国民族医药杂志,2021,27(07):14-16.
[11] 兴安.蒙药额日敦乌日勒治疗糖尿病末梢神经炎的临床疗效评价[D].内蒙古民族大学,2023.
[12] 龚翠琴,万全.蒙药珍宝丸降低紫杉醇所致周围神经毒性的临床观察[J].中国中医药科技,2014,21(04):461-462.